Medicare Policy at the Crossroads: Addressing Artificial Intelligence and Software

AUSTIN, Texas – October 8, 2026 – Paradromics Inc., a neurotechnology company developing high-data-rate brain-computer interfaces (BCIs) to restore and enhance human capabilities, today announced that its brain-computer interface has demonstrated more than four years of stable neural recording and decoding performance.

Explore the engineering, technology and compliance shifts shaping medtech in 2026, from patient-centric innovation to evolving global frameworks.

Explore how Physical AI is transforming medtech and the key challenges around trust, regulation, integration and collaboration that will shape its future.

Kirsten Tullia shares how AdvaMed Digital Health Tech priorities—from AI and cybersecurity to payment and data—will come to life at #MTC26 in Boston.

WASHINGTON—Scott Whitaker, president and CEO of AdvaMed, the medtech association, today welcomed the expiration of the moratorium on Medicare acceptance of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) suppliers. He made the following comment on the expiration. 

 “The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery. This edition features Kelly Huang, CEO of Elucid, an AI medical technology company focused on providing physicians with a more precise, non-invasive view of atherosclerosis to drive patient-specific cardiovascular care.  

Join Suntra MedTech as they explore how AI is beginning to reshape the work of Quality and Regulatory—and what must not change.

AdvaMed’s recent submission to the Food and Drug Administration (FDA) provides comments on the Agency’s revised draft guidance governing communications between drug and device manufacturers and payors, formulary committees, and similar entities.